Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Middle Meningeal Artery (MMA) Embolization for cSDH: Rationale and Design for the STOp Recurrence of MMA Bleeding (STORMM) Randomized-Control Trial

NCT06163547 is registered in ClinicalTrials.gov with University Hospital, Geneva as lead sponsor.

NCT NCT06163547
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06163547 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Middle Meningeal Artery (MMA) Embolization for cSDH: Rationale and Design for the STOp Recurrence of MMA Bleeding (STORMM) Randomized-Control Trial
Lead sponsor
University Hospital, Geneva
Phase
Not applicable
Overall status
Recruiting
Start date
February 18, 2025
Completion date
January 1, 2027
Enrollment
180 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral compression due to injury, chronic subdural hematomas